World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 13 January 2015
Main ID:  ISRCTN97145188
Date of registration: 12/09/2005
Prospective Registration: No
Primary sponsor: Dutch Cancer Society (The Netherlands)
Public title: Patient involvement in prostate cancer treatment decisions
Scientific title:
Date of first enrolment: 01/01/2001
Target sample size: 300
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN97145188
Study type:  Interventional
Study design:  Non randomised controlled trial (Treatment)  
Phase: 
Countries of recruitment
Netherlands
Contacts
Name: PFM    Stalmeier
Address:  Radboud University Nijmegen MC MTA 138 PO Box 9101 6500 HB Nijmegen Netherlands
Telephone: +31 (0)24 3610592
Email: p.stalmeier@mta.umcn.nl
Affiliation: 
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Patients with prostate cancer referred for radiotherapy with curative intent are eligible.
Exclusion criteria: Labile personality structure, as assessed by the physicians, and lack of understanding of the Dutch language.

Age minimum:
Age maximum:
Gender: Male
Health Condition(s) or Problem(s) studied
Prostate cancer
Cancer
Prostate cancer
Intervention(s)
Control group is usual care (150 patients). Intervention group is usual care plus decision aid (150 patients).
Primary Outcome(s)
Primary outcome measure is choice acceptance. At the end of the interview, the patient is asked whether he wants to choose one of the two treatment options, or whether he wants to leave the decision to the physician. The response to this question is choice acceptance. Choice acceptance is confirmed by telephone 2 days later. This measure is obtained about 10 days after the first consultation.
Secondary Outcome(s)
1. Substitute preferences of physicians
2. Quality of life measures
3. Decision evaluation measures
4. Coping measures
5. Knowledge measures
6. Treatment preferences
Secondary ID(s)
Dutch Cancer Society 2001-2379; NTR63
Source(s) of Monetary Support
Dutch Cancer Society
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history